🔎 Trials Near Me

Hjem › Kronisk lymfatisk leukemi › Utah › Salt Lake City

Kliniske studier for Kronisk lymfatisk leukemi i Salt Lake City, UT

10 studier for Kronisk lymfatisk leukemi søker deltakere på steder i og rundt Salt Lake City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

RekruttererFase 3
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT04269902

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

RekruttererFase 3
  • Huntsman Cancer Institute, Salt Lake City
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07277231

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

RekruttererFase 2
  • University of Utah, Salt Lake City
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07221500

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

RekruttererFase 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Alder 18 og eldre · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07061951

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

RekruttererFase 1
  • Huntsman Cancer Institute at The University of Utah, Salt Lake City
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT05091424

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

RekruttererFase 1
  • University of Utah, Salt Lake City
Alder 13 og eldre · Alle kjønn · Oppdatert 5. mai 2026 · NCT04771572

Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial

RekruttererFase 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Alder 18 og eldre · Alle kjønn · Oppdatert 9. apr. 2026 · NCT05183854

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

RekruttererFase 1
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Alder 18 og eldre · Alle kjønn · Oppdatert 20. mar. 2026 · NCT04830137

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

RekruttererFase 2
  • Huntsman Cancer Institute at University of Utah, Salt Lake City
Alder 18 og eldre · Alle kjønn · Oppdatert 3. des. 2025 · NCT04844528

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

RekruttererFase 1/2
  • University of Utah, Salt Lake City
Alder 18 og eldre · Alle kjønn · Oppdatert 14. nov. 2025 · NCT05643742

Kronisk lymfatisk leukemi-studier i andre byer

Andre studier i Salt Lake City

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.